Modeling All age groups Tuberculosis
Efficacy/effectiveness Safety Newborn (0-1 years) Adolescents (10-18 years) Adults (18+) Tuberculosis
Efficacy/effectiveness Safety Newborn (0-1 years) Children (2-9 years) Adolescents (10-18 years) Mumps Measles Rubella Varicella
meeting agenda Agenda & Minutes United Kingdom Ebola Yellow fever Influenza Tuberculosis Human papillomavirus (HPV)
Download:
Efficacy/effectiveness Safety Coverage All age groups Canada Tuberculosis
Economic aspects All age groups Healthcare workers Tuberculosis
Efficacy/effectiveness Safety Newborn (0-1 years) Adolescents (10-18 years) Adults (18+) Tuberculosis
Efficacy/effectiveness Safety Administration All age groups Tuberculosis
immunodeficiency Agenda & Minutes Germany Measles Mumps Rubella Pertussis Varicella
Download: